No black box warning on record for Lynozyfic
As of the latest FDA labeling reviewed, Lynozyfic (LINVOSELTAMAB-GCPT) does not carry a black box warning. Standard warnings and precautions still apply — see the full Lynozyfic medicine page for the complete safety profile.